-
People moves: Heather Hille takes on IR at The Toro Company as Carole Dupont-Pietri leaves Hermès
16 Oct 2025 09:35 GMT
… at Praxis Precision Medicines and PTC Therapeutics.
‘Alex brings deep expertise in … experience, including leading a successful initial public offering, organizing investor days and building …
-
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
09 Oct 2025 11:30 GMT
… Praxis Precision Medicines and PTC Therapeutics, successfully managing IPOs, secondary offerings, and long …
-
PepGen Seeks $101 Million In U.S. IPO
02 May 2022 23:17 GMT
… developing related treatments include: PTC Therapeutics Sarepta Therapeutics Nippon Shinyaku … ;s enterprise value at IPO (excluding underwriter options) would … Listed bookrunners of the IPO are BofA Securities, SVB … the lead underwriter, and IPOs led by the firm …
-
PepGen Targets IPO For Duchenne Muscular Dystrophy Treatments
22 Apr 2022 20:46 GMT
… are developing related treatments include: PTC Therapeutics (PTCT) Sarepta Therapeutics (SRPT) … in total liabilities. PepGen IPO Details PepGen intends to … . Listed bookrunners of the IPO are BofA Securities, SVB … the lead underwriter and IPOs led by the firm …
-
Your Daily Pharma Scoop: Sanofi To Acquire Ablynx, PTC Therapeutics Announces Data, Lutathera Approved
30 Jan 2018 14:32 GMT
… also completed an U.S. IPO, which has helped in improving … in News: Analysis of PTCT PTC Therapeutics (PTCT) announced positive preliminary data …
-
PTC Therapeutics: Emflaza Sales Run Overshadows Translarna Uncertainty
15 Jan 2018 10:34 GMT
… the outlook for its peer PTC Therapeutics (PTCT) as well. Unlike Sarepta … . PTC - Development Of Duchenne PTC Therapeutics went public in the summer … research on all the latest IPOs, M&A activity and …
-
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
24 Oct 2021 16:24 GMT
… (NYSE: BIO) (after the close)
PTC Therapeutics, Inc. (NASDAQ: PTCT) (after … (before the market open)
IPOs
IPO Pricing
Princeton, New Jersey-based … million shares in an IPO. The Marlborough, Massachusetts- … "CDLA."
IPO Quiet Period Expiry
Exscientia …
-
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
29 Jul 2021 12:56 GMT
… NASDAQ: LGND) (after the close)
PTC Therapeutics, Inc. (NASDAQ: PTCT) (after … Medical Systems (after the close)
IPOs
Nuvalent, Inc., (NASDAQ: NUVL … in cancer, priced its initial public offering of 9.75 million … diseases, priced its upsized IPO of 12.13 million …
About
© 1995-2025